PARKHOSPSNSEPark Medi World LimitedMinimalNeutral
Announced Fri, 15 May · 19:28 IST

Monitoring Agency Report for the Quarter ended March 31, 2026

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹242.20
prior close
₹244.46
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.2-0.7-0.4+2.1+5.2+5.7+6.8+14.9+18.5+21.1+5.5+16.0
Up moveDown movePending
AI summary

Park Medi World Limited submitted its quarterly monitoring report for IPO proceeds utilization. The company raised Rs 7,700 million through an IPO in December 2025 and has utilized Rs 7,023.02 million (91.2%) as of March 31, 2026. The funds were deployed towards repayment of borrowings (Rs 3,800 million fully utilized), capital expenditure for a new hospital in Rohtak (Rs 166.53 million of Rs 605 million), medical equipment purchases (Rs 36.08 million of Rs 274.59 million), and inorganic acquisitions (Rs 1,130 million for KP Institute of Medical Sciences and Krishna Super-speciality Hospital). Rs 676.98 million remains unutilized. The report notes a delay in medical equipment procurement due to extended commercial negotiations and delivery timeline alignment.

Likely market impact

The IPO proceeds deployment appears on track with no material deviations from stated objects. The delay in equipment purchases is not concerning as the company has disclosed plans to utilize unspent proceeds in subsequent periods. The acquisition activity demonstrates successful execution of inorganic growth strategy.